256 related articles for article (PubMed ID: 17009047)
1. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
[TBL] [Abstract][Full Text] [Related]
2. Development of next generation medical countermeasures to nerve agent poisoning.
Wetherell J; Price M; Mumford H; Armstrong S; Scott L
Toxicology; 2007 Apr; 233(1-3):120-7. PubMed ID: 16979808
[TBL] [Abstract][Full Text] [Related]
3. Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties.
Weissman BA; Raveh L
Toxicol Appl Pharmacol; 2008 Oct; 232(2):351-8. PubMed ID: 18680758
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
[TBL] [Abstract][Full Text] [Related]
5. A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig.
Wetherell J; Price M; Mumford H
Neurotoxicology; 2006 Jul; 27(4):485-91. PubMed ID: 16488015
[TBL] [Abstract][Full Text] [Related]
6. Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist.
Turner SR; Chad JE; Price M; Timperley CM; Bird M; Green AC; Tattersall JE
Toxicol Lett; 2011 Sep; 206(1):105-11. PubMed ID: 21641979
[TBL] [Abstract][Full Text] [Related]
7. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes.
Levy A; Chapman S; Cohen G; Raveh L; Rabinovitz I; Manistersky E; Kapon Y; Allon N; Gilat E
J Appl Toxicol; 2004; 24(6):501-4. PubMed ID: 15558827
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning.
Joosen MJ; Bueters TJ; van Helden HP
Arch Toxicol; 2004 Jan; 78(1):34-9. PubMed ID: 14508639
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
10. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning.
Dorandeu F; Mikler JR; Thiermann H; Tenn C; Davidson C; Sawyer TW; Lallement G; Worek F
Toxicology; 2007 Apr; 233(1-3):128-44. PubMed ID: 17092624
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen.
Raveh L; Rabinovitz I; Gilat E; Egoz I; Kapon J; Stavitsky Z; Weissman BA; Brandeis R
Toxicol Appl Pharmacol; 2008 Feb; 227(1):155-62. PubMed ID: 18320638
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Acute experimental tabun-induced intoxication and its therapy in rats.
Krejcová G; Kassa J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S48-52. PubMed ID: 15141977
[TBL] [Abstract][Full Text] [Related]
14. Caramiphen edisylate: an optimal antidote against organophosphate poisoning.
Raveh L; Eisenkraft A; Weissman BA
Toxicology; 2014 Nov; 325():115-24. PubMed ID: 25201353
[TBL] [Abstract][Full Text] [Related]
15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
16. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
Berend S; Vrdoljak AL; Radić B; Kuca K
Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog.
Bonhage MR; Chilcoat CD; Li Q; Melendez V; Flournoy WS
J Vet Pharmacol Ther; 2009 Apr; 32(2):146-53. PubMed ID: 19290944
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
[TBL] [Abstract][Full Text] [Related]
19. Low levels of sarin affect the EEG in marmoset monkeys: a pilot study.
van Helden HP; Vanwersch RA; Kuijpers WC; Trap HC; Philippens IH; Benschop HP
J Appl Toxicol; 2004; 24(6):475-83. PubMed ID: 15558834
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
